Inhibition of Inflammatory Signaling in Tet2 Mutant Preleukemic Cells Mitigates Stress-Induced Abnormalities and Clonal Hematopoiesis.

[1]  Vu Dinh,et al.  Microbial signals drive pre-leukaemic myeloproliferation in a Tet2-deficient host , 2018, Nature.

[2]  D. Goukassian,et al.  Tet2-Mediated Clonal Hematopoiesis Accelerates Heart Failure Through a Mechanism Involving the IL-1β/NLRP3 Inflammasome. , 2018, Journal of the American College of Cardiology.

[3]  R. Wells,et al.  An inflammatory environment containing TNFα favors Tet2-mutant clonal hematopoiesis. , 2017, Experimental hematology.

[4]  S. Gabriel,et al.  Clonal Hematopoiesis and Risk of Atherosclerotic Cardiovascular Disease , 2017, The New England journal of medicine.

[5]  Matthew A. Cooper,et al.  Clonal hematopoiesis associated with TET2 deficiency accelerates atherosclerosis development in mice , 2017, Science.

[6]  M. Kimmel,et al.  Chronic Infection Depletes Hematopoietic Stem Cells through Stress-Induced Terminal Differentiation. , 2016, Cell reports.

[7]  B. Ebert,et al.  The genetics of myelodysplastic syndrome: from clonal haematopoiesis to secondary leukaemia , 2016, Nature Reviews Cancer.

[8]  J. Rinn,et al.  The long non-coding RNA Morrbid regulates Bim and short-lived myeloid cell lifespan , 2016, Nature.

[9]  Ping Zhu,et al.  Allosteric inhibition of SHP2 phosphatase inhibits cancers driven by receptor tyrosine kinases , 2016, Nature.

[10]  E. Pietras,et al.  Chronic interleukin-1 drives haematopoietic stem cells towards precocious myeloid differentiation at the expense of self-renewal , 2016, Nature Cell Biology.

[11]  T. Barbui,et al.  Myeloproliferative neoplasms and inflammation: whether to target the malignant clone or the inflammatory process or both , 2016, Leukemia.

[12]  T. Suda,et al.  How hematopoietic stem/progenitors and their niche sense and respond to infectious stress. , 2016, Experimental hematology.

[13]  J. Klawitter,et al.  Aging-associated inflammation promotes selection for adaptive oncogenic events in B cell progenitors. , 2015, The Journal of clinical investigation.

[14]  Angela G. Fleischman.  Inflammation as a Driver of Clonal Evolution in Myeloproliferative Neoplasm , 2015, Mediators of inflammation.

[15]  Xia Li,et al.  Tet2 is required to resolve inflammation by recruiting Hdac2 to specifically repress IL-6 , 2015, Nature.

[16]  D. Baltimore,et al.  Regulation of stress-induced hematopoiesis , 2015, Current opinion in hematology.

[17]  D. Tenen,et al.  Treatment of chronic myelogenous leukemia by blocking cytokine alterations found in normal stem and progenitor cells. , 2015, Cancer cell.

[18]  C. Hunter,et al.  IL-6 as a keystone cytokine in health and disease , 2015, Nature Immunology.

[19]  M. Minden,et al.  Preleukemia: the normal side of cancer , 2015, Current opinion in hematology.

[20]  J. Abkowitz.  Clone wars--the emergence of neoplastic blood-cell clones with aging. , 2014, The New England journal of medicine.

[21]  M. McCarthy,et al.  Age-related clonal hematopoiesis associated with adverse outcomes. , 2014, The New England journal of medicine.

[22]  E. Pietras,et al.  Pro-inflammatory cytokines: emerging players regulating HSC function in normal and diseased hematopoiesis. , 2014, Experimental cell research.

[23]  S. Gabriel,et al.  Clonal hematopoiesis and blood-cancer risk inferred from blood DNA sequence. , 2014, The New England journal of medicine.

[24]  G. Vassiliou,et al.  Acute myeloid leukaemia: a paradigm for the clonal evolution of cancer? , 2014, Disease Models & Mechanisms.

[25]  Markus G. Manz,et al.  Emergency granulopoiesis , 2014, Nature Reviews Immunology.

[26]  Ryan M. O’Connell,et al.  Conversion of danger signals into cytokine signals by hematopoietic stem and progenitor cells for regulation of stress-induced hematopoiesis. , 2014, Cell stem cell.

[27]  Lincoln D. Stein,et al.  Identification of pre-leukemic hematopoietic stem cells in acute leukemia , 2014, Nature.

[28]  E. Pietras,et al.  Re-entry into quiescence protects hematopoietic stem cells from the killing effect of chronic exposure to type I interferons , 2014, The Journal of experimental medicine.

[29]  A. Maitra,et al.  APE1/Ref-1 Regulates STAT3 Transcriptional Activity and APE1/Ref-1–STAT3 Dual-Targeting Effectively Inhibits Pancreatic Cancer Cell Survival , 2012, PloS one.

[30]  Abraham J. Khorasani,et al.  Loss of 5-Hydroxymethylcytosine Is an Epigenetic Hallmark of Melanoma , 2012, Cell.

[31]  Mithat Gonen,et al.  Recurrent Somatic TET2 Mutations in Normal Elderly Individuals With Clonal Hematopoiesis , 2012, Nature Genetics.

[32]  C. Civin,et al.  FLT3-ITD knockin impairs hematopoietic stem cell quiescence/homeostasis, leading to myeloproliferative neoplasm. , 2012, Cell stem cell.

[33]  I. Weissman,et al.  Clonal Evolution of Preleukemic Hematopoietic Stem Cells Precedes Human Acute Myeloid Leukemia , 2012, Science Translational Medicine.

[34]  O. Abdel-Wahab,et al.  The role of mutations in epigenetic regulators in myeloid malignancies , 2012, Nature Reviews Cancer.

[35]  H. Hasselbalch,et al.  Perspectives on chronic inflammation in essential thrombocythemia, polycythemia vera, and myelofibrosis: is chronic inflammation a trigger and driver of clonal evolution and development of accelerated atherosclerosis and second cancer? , 2012, Blood.

[36]  M. Manz,et al.  Demand-adapted regulation of early hematopoiesis in infection and inflammation. , 2012, Blood.

[37]  Carlo C. Maley,et al.  Clonal evolution in cancer , 2012, Nature.

[38]  J. Berg,et al.  Dnmt3a is essential for hematopoietic stem cell differentiation , 2011, Nature Genetics.

[39]  S. Gerson,et al.  Non-Lineage/Stage Restricted Effects of a Gain-of-Function Mutation in Tyrosine Phosphatase Ptpn11 (Shp2) on Malignant Transformation of Hematopoietic Cells , 2011 .

[40]  J. Radich,et al.  IL-6 controls leukemic multipotent progenitor cell fate and contributes to chronic myelogenous leukemia development. , 2011, Cancer cell.

[41]  Feng-Chun Yang,et al.  Deletion of Tet2 in mice leads to dysregulated hematopoietic stem cells and subsequent development of myeloid malignancies. , 2011, Blood.

[42]  Caiying Guo,et al.  Non–lineage/stage-restricted effects of a gain-of-function mutation in tyrosine phosphatase Ptpn11 (Shp2) on malignant transformation of hematopoietic cells , 2011, The Journal of experimental medicine.

[43]  M. Goodell,et al.  Inflammatory modulation of HSCs: viewing the HSC as a foundation for the immune response , 2011, Nature Reviews Immunology.

[44]  K. Rajewsky,et al.  Ten-Eleven-Translocation 2 (TET2) negatively regulates homeostasis and differentiation of hematopoietic stem cells in mice , 2011, Proceedings of the National Academy of Sciences.

[45]  M. Björkholm,et al.  Chronic immune stimulation might act as a trigger for the development of acute myeloid leukemia or myelodysplastic syndromes. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[46]  P. Opolon,et al.  TET2 inactivation results in pleiotropic hematopoietic abnormalities in mouse and is a recurrent event during human lymphomagenesis. , 2011, Cancer cell.

[47]  O. Abdel-Wahab,et al.  Tet2 loss leads to increased hematopoietic stem cell self-renewal and myeloid transformation. , 2011, Cancer cell.

[48]  L. Nie,et al.  Chronic Exposure to a TLR Ligand Injures Hematopoietic Stem Cells , 2011, The Journal of Immunology.

[49]  D. Hanahan,et al.  Hallmarks of Cancer: The Next Generation , 2011, Cell.

[50]  M. Kelley,et al.  Apurinic/Apyrimidinic endonuclease 1 regulates inflammatory response in macrophages. , 2011, Anticancer research.

[51]  L. Aravind,et al.  Impaired hydroxylation of 5-methylcytosine in myeloid cancers with mutant TET2 , 2010, Nature.

[52]  G. Sandusky,et al.  Reduced Expression of DNA Repair and Redox Signaling Protein APE1/Ref-1 Impairs Human Pancreatic Cancer Cell Survival, Proliferation, and Cell Cycle Progression , 2010, Cancer investigation.

[53]  Nathan C Boles,et al.  Quiescent hematopoietic stem cells are activated by IFNγ in response to chronic infection , 2010, Nature.

[54]  M. Karin,et al.  Immunity, Inflammation, and Cancer , 2010, Cell.

[55]  A. Trumpp,et al.  Awakening dormant haematopoietic stem cells , 2010, Nature Reviews Immunology.

[56]  M. Kelley,et al.  Design and synthesis of novel quinone inhibitors targeted to the redox function of apurinic/apyrimidinic endonuclease 1/redox enhancing factor-1 (Ape1/ref-1). , 2010, Journal of medicinal chemistry.

[57]  L. Rahme,et al.  Dysfunctional expansion of hematopoietic stem cells and block of myeloid differentiation in lethal sepsis. , 2009, Blood.

[58]  Andreas Trumpp,et al.  IFNα activates dormant haematopoietic stem cells in vivo , 2009, Nature.

[59]  P. Lio’,et al.  Hematopoietic Stem Cells Reversibly Switch from Dormancy to Self-Renewal during Homeostasis and Repair , 2008, Cell.

[60]  P. Allavena,et al.  Cancer-related inflammation , 2008, Nature.

[61]  W. Yeh,et al.  LPS/TLR4 signal transduction pathway. , 2008, Cytokine.

[62]  S. Morrison,et al.  Supplemental Experimental Procedures , 2022 .

[63]  P. Heinrich,et al.  Principles of interleukin (IL)-6-type cytokine signalling and its regulation. , 2003, The Biochemical journal.

[64]  T. Kosaka,et al.  Bacterial infection promotes colon tumorigenesis in Apc(Min/+) mice. , 2001, The Journal of infectious diseases.

[65]  E. Kliewer,et al.  Cancer risk in patients with inflammatory bowel disease , 2001, Cancer.

[66]  A. Strasser,et al.  Proapoptotic Bcl-2 relative Bim required for certain apoptotic responses, leukocyte homeostasis, and to preclude autoimmunity. , 1999, Science.

[67]  G. Lichtenstein,et al.  Cancer risk in patients with inflammatory bowel disease. , 1999, Gastroenterology clinics of North America.

[68]  Stefanie Sujer.  Lipopolysaccharide-induced activation of haematopoietic stem cells in vivo , 2014 .